Last edition
News about "Everest Medicines"
Shanghai-based Everest Medicines commences operations at its mRNA vaccine manufacturing facility
The first phase of the project, covering an area of 58,000 square meters and with an investment of more than RMB 900 million, has a set of advanced production facilities built to meet global and China GMP standards
<br />
Everest Medicines | 28/12/2022 | By Sudeep Soparkar | 466
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members